Free Trial
OTCMKTS:GTHP

Guided Therapeutics (GTHP) Stock Price, News & Analysis

Guided Therapeutics logo
$0.10 0.00 (-0.10%)
As of 03:55 PM Eastern

About Guided Therapeutics Stock (OTCMKTS:GTHP)

Key Stats

Today's Range
$0.09
$0.10
50-Day Range
$0.08
$0.13
52-Week Range
$0.06
$0.23
Volume
26,251 shs
Average Volume
14,570 shs
Market Capitalization
$7.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Remove Ads
Receive GTHP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GTHP Stock News Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
Guided Therapeutics Inc (GTHP)
Guided Therapeutics Inc
See More Headlines

GTHP Stock Analysis - Frequently Asked Questions

Guided Therapeutics' stock was trading at $0.15 at the beginning of 2025. Since then, GTHP stock has decreased by 33.4% and is now trading at $0.0999.
View the best growth stocks for 2025 here
.

Guided Therapeutics, Inc. (OTCMKTS:GTHP) released its earnings results on Monday, March, 31st. The company reported ($0.02) earnings per share for the quarter.

Shares of GTHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guided Therapeutics investors own include Cornerstone Strategic Value Fund (CLM), Intel (INTC), Beam Therapeutics (BEAM), ChargePoint (CHPT), CSX (CSX), Warner Bros. Discovery (DISCA) and Enbridge (ENB).

Company Calendar

Last Earnings
3/31/2025
Today
4/11/2025
Next Earnings (Estimated)
5/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:GTHP
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,490,000.00
Pretax Margin
-5,660.53%

Debt

Sales & Book Value

Annual Sales
$100,000.00
Price / Cash Flow
N/A
Book Value
($0.13) per share
Price / Book
-0.77

Miscellaneous

Free Float
21,673,000
Market Cap
$7.79 million
Optionable
Not Optionable
Beta
0.42
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:GTHP) was last updated on 4/11/2025 by MarketBeat.com Staff
From Our Partners